ACS Journal Cancer (@journalcancer) 's Twitter Profile
ACS Journal Cancer

@journalcancer

An interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)

ID: 19077568

linkhttp://canceronlinejournal.com calendar_today16-01-2009 18:00:37

11,11K Tweet

30,30K Takipçi

4,4K Takip Edilen

ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

Published in time for #ASCO25: Thoughts from Dena Rhinehart, MD, Nathan E. Rice, and Otis Brawley on trends in cancer incidence and mortality and the COVID-19 pandemic. Accompanies the recent #CancerAnnualReport. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert Johns Hopkins Hematology and Oncology Fellowship ACSNews

Published in time for #ASCO25: Thoughts from <a href="/DenaRhinehart/">Dena Rhinehart, MD</a>, Nathan E. Rice, and <a href="/OtisBrawley/">Otis Brawley</a> on trends in cancer incidence and mortality and the COVID-19 pandemic. Accompanies the recent #CancerAnnualReport. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… <a href="/OncoAlert/">OncoAlert</a> <a href="/Hopkins_HemOnc/">Johns Hopkins Hematology and Oncology Fellowship</a> <a href="/ACSNews/">ACSNews</a>
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

New #OpenAccess commentary published in time for #ASCO25 | Randomized controlled trial reporting guidelines should be updated to include information on subsequent treatments acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… G.J. Melendez-Torres Exeter Med School OncoAlert

New #OpenAccess commentary published in time for #ASCO25 | Randomized controlled trial reporting guidelines should be updated to include information on subsequent treatments acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

<a href="/gjmelendez/">G.J. Melendez-Torres</a> <a href="/ExeterMed/">Exeter Med School</a> <a href="/OncoAlert/">OncoAlert</a>
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

#ASCO25 is officially underway! 🎉 Start the meeting with a must-read: the newly released Annual Report to the Nation on the Status of Cancer—the most up-to-date, comprehensive look at cancer trends in the U.S. 📊📉 🔗 acsjournals.onlinelibrary.wiley.com/doi/full/10.10… OncoAlert Ahmedin Jemal ACSNews

#ASCO25 is officially underway! 🎉 Start the meeting with a must-read: the newly released Annual Report to the Nation on the Status of Cancer—the most up-to-date, comprehensive look at cancer trends in the U.S. 📊📉

🔗 acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

<a href="/OncoAlert/">OncoAlert</a> <a href="/AhJemal/">Ahmedin Jemal</a> <a href="/ACSNews/">ACSNews</a>
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

Coming up at #ASCO25: Section Editor Dr. Saro Armenian joins the Education Session on reducing morbidity in pediatric cancer survivors. 📊 His research shows AYA survivors face higher risks of long-term, high-dose opioid use: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert Saro Armenian

Coming up at #ASCO25: Section Editor Dr. Saro Armenian joins the Education Session on reducing morbidity in pediatric cancer survivors.  

📊 His research shows AYA survivors face higher risks of long-term, high-dose opioid use:
acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

<a href="/OncoAlert/">OncoAlert</a> <a href="/ArmenianSaro/">Saro Armenian</a>
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

#ASCO25 is set to showcase breakthroughs in targeted treatments for non–small cell lung cancer 🫁 🔬 Stay at the forefront of innovation with our latest supplement, Targeted Therapies in #NSCLC: acsjournals.onlinelibrary.wiley.com/toc/10970142/2… OncoAlert Suresh S. Ramalingam, MD, FASCO

ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

Don't miss Dr. Sandip Patel as he leads the upcoming #ASCO25 Education Session on how AI can improve cancer trial design, diversity, and recruitment 🧠📊 Revisit past work from Sandip Patel MD FASCO on equity in clinical research: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert

Don't miss Dr. Sandip Patel as he leads the upcoming #ASCO25 Education Session on how AI can improve cancer trial design, diversity, and recruitment 🧠📊 

Revisit past work from <a href="/PatelOncology/">Sandip Patel MD FASCO</a> on equity in clinical research:
acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

<a href="/OncoAlert/">OncoAlert</a>
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

Dr. Priya Kumthekar of Northwestern Feinberg School of Medicine, our newest Section Editor, chairs the approaching #ASCO25 case-based panel on treatment & diagnostic advances for leptomeningeal disease. Find Dr. Kumthekar and our full suite of Editors on our website: acsjournals.onlinelibrary.wiley.com/hub/journal/10… OncoAlert

Dr. Priya Kumthekar of <a href="/NUFeinbergMed/">Northwestern Feinberg School of Medicine</a>, our newest Section Editor, chairs the approaching #ASCO25 case-based panel on treatment &amp; diagnostic advances for leptomeningeal disease.

Find Dr. Kumthekar and our full suite of Editors on our website:
acsjournals.onlinelibrary.wiley.com/hub/journal/10…

<a href="/OncoAlert/">OncoAlert</a>
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

#ASCO25 Poster spotlight🔦Editorial Advisory Board member Dr. Stephanie Smith presents research on community-led support to improve Hispanic/Latino young adult cancer survivorship care🤝 See her related insights on racism & survivor health: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert

#ASCO25 Poster spotlight🔦Editorial Advisory Board member Dr. Stephanie Smith presents research on community-led support to improve Hispanic/Latino young adult cancer survivorship care🤝 

See her related insights on racism &amp; survivor health:
acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

<a href="/OncoAlert/">OncoAlert</a>
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

🚀 #ASCO25 features a notable number of presentations spotlighting small cell lung cancer, signaling momentum in research, innovation & patient care. Stay in the know with the latest advances in #SCLC: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert Misty Dawn Shields Anne Chiang Lauren Averett Byers, MD

ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

🎉Congrats to Dr. Sandip Patel, Cancer's Developmental Therapeutics & Social Media Editor, & ASCO Fellow, on receipt of his #ASCO25 Award later this morning! 🏆 See his recent work on immunotx for advanced gallbladder cancer: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert Sandip Patel MD FASCO

🎉Congrats to Dr. Sandip Patel, Cancer's Developmental Therapeutics &amp; Social Media Editor, &amp; <a href="/ASCO/">ASCO</a> Fellow, on receipt of his #ASCO25 Award later this morning! 🏆 

See his recent work on immunotx for advanced gallbladder cancer:
acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

<a href="/OncoAlert/">OncoAlert</a> <a href="/PatelOncology/">Sandip Patel MD FASCO</a>
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

👏 Join us in celebrating Dr. Suzanne Dahlberg—biostatistician, clinical trials expert, #PedOnc researcher Boston Children's, Cancer Editorial Advisory Board member & ASCO Fellow. 🎉 She receives the prestigious #ASCO25 FASCO Award today at 11:30am! OncoAlert Suzanne Dahlberg

👏 Join us in celebrating Dr. Suzanne Dahlberg—biostatistician, clinical trials expert, #PedOnc researcher <a href="/BostonChildrens/">Boston Children's</a>, Cancer Editorial Advisory Board member &amp; <a href="/ASCO/">ASCO</a> Fellow. 🎉

She receives the prestigious #ASCO25 FASCO Award today at 11:30am!

<a href="/OncoAlert/">OncoAlert</a> <a href="/SuzDahlberg/">Suzanne Dahlberg</a>
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

Stop by the #ASCO25 Poster Session to learn about targeted treatments for BRAF-mutated NSCLC🧬 📗Available in our Targeted Therapies in NSCLC supplement, this review illuminates how new treatments are improving outcomes: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert d.planchard

Stop by the #ASCO25 Poster Session to learn about targeted treatments for BRAF-mutated NSCLC🧬

📗Available in our Targeted Therapies in NSCLC supplement, this review illuminates how new treatments are improving outcomes:
acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

<a href="/OncoAlert/">OncoAlert</a> <a href="/dplanchard/">d.planchard</a>
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

️Take a break between #ASCO25 sessions and tune in to CancerSpeak, the official podcast from CANCER. 🎙️ CancerSpeak covers the latest in oncology research, treatment, and patient care. Available here and wherever you get your podcasts: cancerspeak.podbean.com OncoAlert

ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

At #ASCO25, "We’ve only GIST begun!"🚀 The approaching Education Session covers key challenges, mutations, & new therapies in GIST. Dr. Jason Sicklick, Cancer Editorial Advisory Board member, presents. His work has deeply shaped the field: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert

At #ASCO25, "We’ve only GIST begun!"🚀 The approaching Education Session covers key challenges, mutations, &amp; new therapies in GIST.  

Dr. <a href="/JasonSicklick/">Jason Sicklick</a>, Cancer Editorial Advisory Board member, presents. His work has deeply shaped the field: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

<a href="/OncoAlert/">OncoAlert</a>
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

At 9am, the #ASCO25 Care Delivery and Quality Care Poster Session spotlights cancer care disparities. 🎧 Before you go, hear Lauren E. McCullough & camille ragin on CancerSpeak as they discuss the American Cancer Society VOICES of Black Women Study: cancerspeak.podbean.com/e/the-voices-o… OncoAlert

ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

Breakthroughs in cancer care delivery are on display at this morning's #ASCO25 Poster Session. For a deeper dive into targeted therapy advances for lung cancer, read the expert commentary by Drs. Maisam Makarem & Pasi Jänne: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert Dana-Farber #NSCLC

ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

Coming up! Section Editor Jason Luke, MD, FACP presents 2 major melanoma trials at #ASCO25: 📌 IGNYTE-3 (vusolimogene + nivolumab) 📌 TeLuRide-006 (TLR7/8 agonist + pembrolizumab) More from Dr. Luke on neoadjuvant immunotherapy for melanoma: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert

Coming up! Section Editor <a href="/jasonlukemd/">Jason Luke, MD, FACP</a> presents 2 major melanoma trials at #ASCO25:

📌 IGNYTE-3 (vusolimogene + nivolumab)
📌 TeLuRide-006 (TLR7/8 agonist + pembrolizumab)

More from Dr. Luke on neoadjuvant immunotherapy for melanoma: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

<a href="/OncoAlert/">OncoAlert</a>
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

Join the 1pm #ASCO25 Plenary Session for top oncology research! On your way to McCormick Place, tune into CancerSpeak for key takeaways from the ESMO 2024 Congress, including advances in melanoma, immunotherapy, & social media in oncology. 🎧 cancerspeak.podbean.com/e/key-highligh… OncoAlert

ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

🚨 Happening now at #ASCO25! The Lung Cancer Rapid Oral Abstract session features key updates on ALK+ #NSCLC 🫁 📗 From a review in the Targeted Therapies in NSCLC supplement: ALK therapies are improving survival and changing treatment: acsjournals.onlinelibrary.wiley.com/doi/epdf/10.10… OncoAlert

🚨 Happening now at #ASCO25! The Lung Cancer Rapid Oral Abstract session features key updates on ALK+ #NSCLC 🫁

📗 From a review in the Targeted Therapies in NSCLC supplement: ALK therapies are improving survival and changing treatment:
acsjournals.onlinelibrary.wiley.com/doi/epdf/10.10…

<a href="/OncoAlert/">OncoAlert</a>
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

Seeking a data-driven read during #ASCO25? 📊 Check out the newly released Annual Report to the Nation on the Status of Cancer—a detailed snapshot of U.S. cancer statistics. Essential reading for anyone tracking cancer control progress: 🔗 acsjournals.onlinelibrary.wiley.com/doi/full/10.10… OncoAlert

Seeking a data-driven read during #ASCO25? 📊 Check out the newly released Annual Report to the Nation on the Status of Cancer—a detailed snapshot of U.S. cancer statistics. 

Essential reading for anyone tracking cancer control progress:
🔗 acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

<a href="/OncoAlert/">OncoAlert</a>